STOCK TITAN

PBYI (NASDAQ: PBYI) holder plans Rule 144 sale of 3,973 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An affiliate of the issuer has filed a notice of proposed sale under Rule 144 covering up to 3,973 shares of common stock. These shares are planned to be sold through Fidelity Brokerage Services LLC on the NASDAQ, with an approximate sale date of 01/06/2026 and an indicated aggregate market value of 23,216.62. The filing notes that 50,391,107 shares of this class were outstanding at the time referenced.

The 3,973 shares were acquired on 01/02/2026 directly from the issuer through restricted stock vesting as compensation. The section for securities sold during the past three months does not list any prior sales, and the signer represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many PBYI common shares are covered by this Rule 144 notice?

The notice covers up to 3,973 shares of common stock to be sold under Rule 144.

What is the aggregate market value of the PBYI shares to be sold?

The filing lists an aggregate market value of 23,216.62 for the 3,973 common shares proposed to be sold.

When were the PBYI shares acquired and how were they obtained?

The 3,973 common shares were acquired on 01/02/2026 via restricted stock vesting from the issuer as compensation.

When is the approximate sale date and where will the PBYI shares trade?

The approximate sale date is 01/06/2026, with the shares to be sold through Fidelity Brokerage Services LLC on the NASDAQ exchange.

How many shares of this class of PBYI stock were outstanding?

The filing states that there were 50,391,107 shares of this class of common stock outstanding at the referenced time.

Does the filer report any PBYI share sales in the prior three months?

The section for securities sold during the past three months is present but does not list any prior sales for the person whose account is selling these shares.

What representation does the seller make about information on the PBYI issuer?

By signing, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
Puma Biotechnology Inc

NASDAQ:PBYI

PBYI Rankings

PBYI Latest News

PBYI Latest SEC Filings

PBYI Stock Data

321.50M
42.72M
15.43%
68.25%
5.49%
Biotechnology
Pharmaceutical Preparations
Link
United States
LOS ANGELES